Examining the safety of CNS stimulants in veterans with brain injuries
Understanding CNS Stimulant Use and Safety in Veterans with TBI
This study is looking at how safe it is for veterans with traumatic brain injuries to use certain medications that help with focus and energy, and it hopes to find helpful information to improve their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | U.s. Dept/vets Affairs Medical Center NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11099682 on NIH RePORTER |
What this research studies
This research investigates the use of central nervous system (CNS) stimulants in veterans who have experienced traumatic brain injury (TBI). It aims to understand the safety and potential risks associated with these medications, particularly given their association with substance use disorders. The study will analyze data from veterans' health records to assess the prevalence of CNS stimulant prescriptions and their effects on veterans with TBI. By focusing on this population, the research seeks to provide insights that could inform treatment guidelines and improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans diagnosed with traumatic brain injury, particularly those who have been prescribed CNS stimulants.
Not a fit: Patients without a diagnosis of traumatic brain injury or those not prescribed CNS stimulants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer treatment options for veterans with TBI, reducing the risk of substance use disorders.
How similar studies have performed: This research addresses a novel question regarding CNS stimulant use in veterans with TBI, as similar studies have not been conducted previously.
Where this research is happening
Washington, United States
- U.s. Dept/vets Affairs Medical Center — Washington, United States (Active)
Researchers
- Principal investigator: Faselis, Charles J — U.s. Dept/vets Affairs Medical Center
- Study coordinator: Faselis, Charles J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.